Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamran Idrees

Showing results (71-80 of 154) with videos related to

Pageof 16
Sort By:
Npj Metabolic Health and Disease|March 17, 2025
Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progressionSandesh J Marathe, Emily W Grey, Margaret S Bohm, et al.
JAMA Network Open|February 4, 2026
Demographic and Clinicopathologic Factors Associated With Colorectal Adenoma RecurrenceUsman Ayub Awan, Qingyuan Song, Kristen K Ciombor, et al.
Journal of Surgical Oncology|August 31, 2019
Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysisLu Wu, Kota Sahara, Diamantis I Tsilimigras, et al.
Journal of Surgical Oncology|January 11, 2026
Insulin-Dependence and Survival in Pancreatic Neuroendocrine Tumors: Results From the US-NTSG GroupMuhammad Bilal Mirza, Jordan J Baechle, Paula Marincola Smith, et al.
Journal of Health Communication|September 24, 2016
The Impact of Health Literacy on Surgical Outcomes Following Radical CystectomyKristen R Scarpato, Stephen F Kappa, Kathryn M Goggins, et al.
Surgery|May 11, 2019
The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical managementAlexandra G Lopez-Aguiar, Cecilia G Ethun, Mohammad Y Zaidi, et al.
Journal of Surgical Oncology|August 7, 2019
Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?Danielle K DePalo, Rachel M Lee, Alexandra G Lopez-Aguiar, et al.
Annals of Surgical Oncology|October 16, 2025
Perineural Invasion Worsens Long-Term Outcomes of Pancreatic Neuroendocrine Tumors Following Surgical ResectionHui Xu, Jing-Jing Hou, Jun-Xi Xiang, et al.
Journal of Surgical Oncology|January 8, 2020
Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortiumKota Sahara, Diamantis I Tsilimigras, Shishir K Maithel, et al.
Neuroendocrinology|September 13, 2023
Low Prognostic Nutritional Index Is Common and Associated with Poor Outcomes following Curative-Intent Resection for Gastro-Entero-Pancreatic Neuroendocrine TumorsJun-Xi Xiang, Ye-Rong Qian, Jin He, et al.
Pageof 16

Showing results (71-80 of 154) with videos related to

Sort By:
Pageof 16
Npj Metabolic Health and Disease|March 17, 2025
Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progressionSandesh J Marathe, Emily W Grey, Margaret S Bohm, et al.
JAMA Network Open|February 4, 2026
Demographic and Clinicopathologic Factors Associated With Colorectal Adenoma RecurrenceUsman Ayub Awan, Qingyuan Song, Kristen K Ciombor, et al.
Journal of Surgical Oncology|August 31, 2019
Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysisLu Wu, Kota Sahara, Diamantis I Tsilimigras, et al.
Journal of Surgical Oncology|January 11, 2026
Insulin-Dependence and Survival in Pancreatic Neuroendocrine Tumors: Results From the US-NTSG GroupMuhammad Bilal Mirza, Jordan J Baechle, Paula Marincola Smith, et al.
Journal of Health Communication|September 24, 2016
The Impact of Health Literacy on Surgical Outcomes Following Radical CystectomyKristen R Scarpato, Stephen F Kappa, Kathryn M Goggins, et al.
Surgery|May 11, 2019
The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical managementAlexandra G Lopez-Aguiar, Cecilia G Ethun, Mohammad Y Zaidi, et al.
Journal of Surgical Oncology|August 7, 2019
Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?Danielle K DePalo, Rachel M Lee, Alexandra G Lopez-Aguiar, et al.
Annals of Surgical Oncology|October 16, 2025
Perineural Invasion Worsens Long-Term Outcomes of Pancreatic Neuroendocrine Tumors Following Surgical ResectionHui Xu, Jing-Jing Hou, Jun-Xi Xiang, et al.
Journal of Surgical Oncology|January 8, 2020
Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortiumKota Sahara, Diamantis I Tsilimigras, Shishir K Maithel, et al.
Neuroendocrinology|September 13, 2023
Low Prognostic Nutritional Index Is Common and Associated with Poor Outcomes following Curative-Intent Resection for Gastro-Entero-Pancreatic Neuroendocrine TumorsJun-Xi Xiang, Ye-Rong Qian, Jin He, et al.
Pageof 16